Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISA 2022 | Targeting oligomeric species to combat Parkinson’s disease

Daniel Otzen, PhD, Aarhus University, Aarhus, Denmark, comments on the rationale for targeting oligomeric species in Parkinson’s disease, highlighting the challenges of this approach. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.